Strata Oncology logo

Strata Oncology

Strata Oncology is improving enrollment in precision oncology clinical trials by providing genetic sequencing for late-stage cancer patients.

strataoncology.com
Ann Arbor, MI

CEO: Dan Rhodes
Arboretum Lead: Jan Garfinkle

IN THE NEWS
May 11, 2022 in Home Page, News Page, Strata Oncology

Strata Oncology Enrolls First Patient in Strata PATH Trial

Strata Oncology, Inc., a next-generation precision oncology company enabling smarter and earlier cancer treatment, today announced enrollment of the first patient in the Strata Precision Indications for Approved THerapies (Strata PATHTM) trial,…
Read More
March 9, 2022 in Home Page, News Page, Strata Oncology

Strata Oncology Named to Fast Company’s Annual List of the World’s 50 Most Innovative Companies for 2022

Strata Oncology, a precision oncology company advancing new molecular indications for cancer therapies, has been named to Fast Company's prestigious annual list of the World's Most Innovative Companies for 2022.
Read More